Myc-stress in particular may affect alternative splicing through spliceosome complexes in cancers [4, 5]; therefore, core spliceosomes are a promising target for the treatment of c-Myc-driven cancers [4, 5, 6]. The gene discussed is MYC; the disease is cancer.